TODENTJ-25-03-2019_TODENTJ-10-752
1553506908
Bentham Open
doi@benthamopen.net
Bentham Open
The Open Dentistry Journal
TODENTJ
1874-2106
12
30
2016
10
1
Expression of Vascular Endothelial Growth Factor in Odontogenic Cysts: Is There Any Impression on Clinical Outcome?
Donia
Sadri
Sareh
Farhadi
Zahra
Shahabi
Samaneh
Sarshar
Background:
The recent scientific reports have shown that angiogenesis can affect biological behavior of pathologic lesions.
Objective:
Regarding unique clinical outcome of Odontogenic keratocyst (OKC), the present study was aimed to compare angiogenesis in Odontogenic keratocyst and Dentigerous cyst (DC).
Method:
In this experimental study, tissue sections of 46 samples of OKC and DC were stained through immunohistochemical method using Vascular Endothelial Growth Factor (VEGF) antibody. VEGF expression was evaluated in epithelial cells, fibroblasts and endothelial cells. The average percentage of stained cells in any samples was categorized to 3 groups as follows: SCORE 0: 10% of cells or less are positive. SCORE 1: 10 to 50% of cells are positive. SCORE 2: more than 50% of cells are positive. Mann-U-Whitney, T-test and chi-square was used for statistical analysis.
Result:
The average of VEGF expression in 24 samples of DC was 20.2% and in 22 samples of OKC was 52.6%, respectively. The average of VEGF expression in these two cysts had statistical significant differences. (PV= 0.045). There was significant statistical differences between two cysts in the terms of VEGF SCORE (PV= 0.000). OKC samples had significantly higher SCORE for the purpose of VEGF incidence than DC. Also, there were no differences between VEGF expression in epithelial cells of two cysts (PV= 0.268) there were significant statistical differences between two cysts in terms of endothelial cell staining. The endothelial cell staining was significantly higher in OKC than DC (PV= 0.037%).
Conclusion:
Regarding higher expression of Vascular Endothelial Growth factor in OKC than DC, it seems that angiogenesis may have great impression on clinical outcome of OKC.
12
30
2016
752
759
TODENTJ-10-752
1
10.2174/crossmark_policy
opendentistryjournal.com
benthamopen.com
true
Peer Reviewed
Single blind
Checked with iThenticate
2016-07-25
2016-11-06
2016-12-08
2016-12-30
https://creativecommons.org/licenses/by/4.0/legalcode
10.2174/1874210601610010752
1553506908
https://opendentistryjournal.com/VOLUME/10/PAGE/752/
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.pdf
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.pdf
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.pdf
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.pdf
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.pdf
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.pdf
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.pdf
-
https://opendentistryjournal.com/contents/volumes/V10/TODENTJ-10-752/TODENTJ-10-752.xml
Biotech. Histochem.
Patidar K.A.
87
397
2012
10.3109/10520295.2012.674556
Patidar KA, Parwani RN, Wanjari SP, Patidar AP.
Mast cells in human odontogenic cysts.
Biotech Histochem
2012;
87
(6)
: 397-402.
Neville B, Damm D, Allen C.
Oral & Maxillofacial Pathology. 3rd ed.
Philadelphia: WB Saunders co. 2009; pp.
678-701.
Regezi JA, Sciubba JJ, Jordan RC.
Oral pathology: clinical pathologic correlations. 6th ed.
St Louis: Saunders Elsevier 2011; pp.
237-51.
J. Emerg. Med.
Akyol U.K.
43
1004
2012
10.1016/j.jemermed.2010.11.045
Akyol UK, Salman IA.
A case of an extensive dentigerous cyst in the maxillary sinus leading to epiphora and nasal obstruction.
J Emerg Med
2012;
43
(6)
: 1004-7.
Oral Oncol.
Shear M.
38
219
2002
10.1016/S1368-8375(01)00065-3
Shear M.
The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour.
Oral Oncol
2002;
38
(3)
: 219-26.
Oral Dis.
Thosaporn W.
10
22
2004
10.1046/j.1354-523X.2003.00974.x
Thosaporn W, Iamaroon A, Pongsiriwet S, Ng KH.
A comparative study of epithelial cell proliferation between the odontogenic keratocyst, orthokeratinized odontogenic cyst, dentigerous cyst, and ameloblastoma.
Oral Dis
2004;
10
(1)
: 22-6.
J. Oral Pathol. Med.
Tsuneki M.
37
287
2008
10.1111/j.1600-0714.2007.00620.x
Tsuneki M, Cheng J, Maruyama S, Ida-Yonemochi H, Nakajima M, Saku T.
Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor.
J Oral Pathol Med
2008;
37
(5)
: 287-93.
J. Clin. Diagn. Res.
Puthiyaveetil J.S.
10
ZE05
2016
Puthiyaveetil JS, Kota K, Chakkarayan R, Chakkarayan J, Thodiyil AK.
Epithelial - mesenchymal interactions in tooth development and the significant role of growth factors and genes with emphasis on mesenchyme - a review.
J Clin Diagn Res
2016;
10
(9)
: ZE05-9.
Nat. Med.
Folkman J.
1
27
1995
10.1038/nm0195-27
Folkman J.
Angiogenesis in cancer, vascular, rheumatoid and other disease.
Nat Med
1995;
1
(1)
: 27-31.
EXS
Brown L.F.
79
233
1997
10.1007/978-3-0348-9006-9_10
Brown LF, Detmar M, Claffey K, et al.
Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
EXS
1997;
79
: 233-69.
Endocr. Rev.
Ferrara N.
18
4
1997
10.1210/edrv.18.1.0287
Ferrara N, Davis-Smyth T.
The biology of vascular endothelial growth factor.
Endocr Rev
1997;
18
(1)
: 4-25.
Breast Cancer
Maruthanila V.L.
2016
10.1007/s12282-016-0732-1
Maruthanila VL, Elancheran R, Kunnumakkara AB, Kabilan S, Kotoky J.
Recent development of targeted approaches for the treatment of breast cancer.
Breast Cancer
2016.
[Epub ahead of print]
Oncotarget
Gaustad J.V.
2016
10.18632/oncotarget.12695
Gaustad JV, Simonsen TG, Andersen LM, Rofstad EK.
Properdistatin inhibits angiogenesis and improves vascular function in human melanoma xenografts with low thrombospondin-1 expression.
Oncotarget
2016.
[Epub ahead of print]
J. Contemp. Dent. Pract.
Shahsavari F.
16
458
2015
10.5005/jp-journals-10024-1706
Shahsavari F, Farhadi S, Sadri D, Sedehi M.
Evaluation of microvascularity by CD34 expression in esophagus and oral squamous cell carcinoma.
J Contemp Dent Pract
2015;
16
(6)
: 458-62.
Oral Dis.
Alaeddini M.
15
422
2009
10.1111/j.1601-0825.2009.01566.x
Alaeddini M, Salah S, Dehghan F, Eshghyar N, Etemad-Moghadam S.
Comparison of angiogenesis in keratocystic odontogenic tumours, dentigerous cysts and ameloblastomas.
Oral Dis
2009;
15
(6)
: 422-7.
Indian J. Pathol Microbiol.
Sargolzaei S.
57
24
2014
10.4103/0377-4929.130877
Sargolzaei S, Farhadi S, Kazemi B, Bandehpour M, Kharazifard MJ.
The correlation between p16 expression and INK4a locus mutation with grades and stages in oral squamous cell carcinoma.
Indian J Pathol Microbiol
2014;
57
(1)
: 24-30.
Asian Pac. J. Cancer Prev.
Seifi S.
12
351
2011
Seifi S, Shafaie S, Ghadiri S.
Microvessel density in follicular cysts, keratocystic odontogenic tumours and ameloblastomas.
Asian Pac J Cancer Prev
2011;
12
(2)
: 351-6.
Clin. Oral Investig.
Rubini C.
15
757
2011
10.1007/s00784-010-0433-7
Rubini C, Artese L, Zizzi A, et al.
Immunohistochemical expression of vascular endothelial growth factor (VEGF) in different types of odontogenic cysts.
Clin Oral Investig
2011;
15
(5)
: 757-61.
Oral. pathol. Med.
Mitrou GK
38
470
2009
Mitrou GK.
Odontogenic keratocyst expression vascular endothelial growth factor an immunohistochemical study.
Oral pathol Med
2009;
38
(5)
: 470-5.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
Nonaka C.F.
106
896
2008
10.1016/j.tripleo.2008.06.028
Nonaka CF, Maia AP, Nascimento GJ, de Almeida Freitas R, Batista de Souza L, Galvão HC.
Immunoexpression of vascular endothelial growth factor in periapical granulomas, radicular cysts, and residual radicular cysts.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2008;
106
(6)
: 896-902.
J. Endod.
Leonardi R.
29
180
2003
10.1097/00004770-200303000-00004
Leonardi R, Caltabiano M, Pagano M, Pezzuto V, Loreto C, Palestro G.
Detection of vascular endothelial growth factor/ vascular permeability factor in periapical lesions.
J Endod
2003;
29
(3)
: 180-3.
Br. J. Dermatol.
Amo Y.
150
160
2004
10.1111/j.1365-2133.2004.05751.x
Amo Y, Masuzawa M, Hamada Y, Katsuoka K.
Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients.
Br J Dermatol
2004;
150
(1)
: 160-1.
J. Am. Soc. Nephrol.
Liu E.
18
2094
2007
10.1681/ASN.2006010075
Liu E, Morimoto M, Kitajima S, et al.
Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.
J Am Soc Nephrol
2007;
18
(7)
: 2094-104.
Asian Pac. J. Cancer Prev.
Farhadi S.
17
673
2016
10.7314/APJCP.2016.17.2.673
Farhadi S, Shahsavari F, Taleghani F, Komasi E.
Mast cell concentrations in peripheral and central giant cell granulomas: is there any angiogenetic role?
Asian Pac J Cancer Prev
2016;
17
(2)
: 673-6.
Nat. Med.
Ferrara N.
4
336
1998
10.1038/nm0398-336
Ferrara N, Chen H, Davis-Smyth T, et al.
Vascular endothelial growth factor is essential for corpus luteum angiogenesis.
Nat Med
1998;
4
(3)
: 336-40.
J. Oral Pathol. Med.
Kumamoto H.
31
28
2002
10.1046/j.0904-2512.2001.10061.x
Kumamoto H, Ohki K, Ooya K.
Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
J Oral Pathol Med
2002;
31
(1)
: 28-34.
J. Leukoc. Biol.
Dvorak A.M.
59
100
1996
Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF.
The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation.
J Leukoc Biol
1996;
59
(1)
: 100-15.
Ann. N. Y. Acad. Sci.
Dvorak H.F.
667
101
1992
10.1111/j.1749-6632.1992.tb51603.x
Dvorak HF, Nagy JA, Berse B, et al.
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.
Ann N Y Acad Sci
1992;
667
: 101-11.
Arterioscler. Thromb. Vasc. Biol.
Claesson-Welsh L.
28
1575
2008
10.1161/ATVBAHA.108.170878
Claesson-Welsh L.
VEGF-B taken to our hearts: specific effect of VEGF-B in myocardial ischemia.
Arterioscler Thromb Vasc Biol
2008;
28
(9)
: 1575-6.
Cell. Signal.
Holmes K.
19
2003
2007
10.1016/j.cellsig.2007.05.013
Holmes K, Roberts OL, Thomas AM, Cross MJ.
Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.
Cell Signal
2007;
19
(10)
: 2003-12.
Oncogene
Karkkainen M.J.
19
5598
2000
10.1038/sj.onc.1203855
Karkkainen MJ, Petrova TV.
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.
Oncogene
2000;
19
(49)
: 5598-605.
Am. J. Physiol. Endocrinol. Metab.
Oltmanns K.M.
290
E434
2006
10.1152/ajpendo.00508.2004
Oltmanns KM, Gehring H, Rudolf S, et al.
Acute hypoxia decreases plasma VEGF concentration in healthy humans.
Am J Physiol Endocrinol Metab
2006;
290
(3)
: E434-9.
J. Oral Pathol. Med.
de Moraes M.
42
468
2013
10.1111/jop.12036
de Moraes M, de Matos FR, de Souza LB, de Almeida Freitas R, de Lisboa Lopes Costa A.
Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts.
J Oral Pathol Med
2013;
42
(6)
: 468-73.
J. Craniofac. Surg.
Laino L.
26
2030
2015
10.1097/SCS.0000000000001947
Laino L, Troiano G, Lo Muzio L, Menditti D, Herford AS, Cicciù M.
Bone healing in the surgical treatment of dentigerous cysts in critically Ill patients.
J Craniofac Surg
2015;
26
(6)
: 2030-1.